New Iridium - About the company
New Iridium is a seed company based in Boulder (United States), founded in 2016 by Chern-Hooi Lim, Brent Cutcliffe and Garrett Miyake. It operates as a Manufacturer of phenoxazine and dihydrophenazine. New Iridium has raised $2.65M in funding from Radicle and CIRI Ventures. The company has 233 active competitors, including 23 funded and 30 that have exited. Its top competitors include companies like Sai Life Sciences, Liverpool ChiroChem and NFIL.
Company Details
- Website
- newiridium.com
Key Metrics
Founded Year
2016
Location
Boulder, United States
Stage
Seed
Total Funding
$2.65M in 6 rounds
Latest Funding Round
Ranked
9th among 233 active competitors
Employee Count
8 as on Mar 31, 2026
Similar Companies
Sign up to download New Iridium's company profile
New Iridium's funding and investors
New Iridium has raised a total funding of $2.65M over 6 rounds. Its first funding round was on Feb 05, 2019. Its latest funding round was a Seed round on Jun 11, 2025 for $*****. 4 investors participated in its latest round. New Iridium has 8 institutional investors.
Here is the list of recent funding rounds of New Iridium:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jun 11, 2025 | 5710714 | Seed | 7335870 | 1150044 | 2118945 | 3881434 |
Jul 22, 2024 | 6233027 | Grant (prize money) | 3188539 | 9584651 | 8811511 | |
Jun 29, 2023 | 3191063 | Grant (prize money) | 7039572 | 8698570 | 6800836 |
View details of New Iridium's funding rounds and investors
New Iridium's founders and board of directors
Founder? Claim ProfileThe founders of New Iridium are Chern-Hooi Lim, Brent Cutcliffe and Garrett Miyake. Chern-Hooi Lim is the CEO of New Iridium.
Here are the details of New Iridium's key team members:
- Chern-Hooi Lim: Founder & CEO of New Iridium. Contact Info: 1 email address
- Brent Cutcliffe: Co-Founder & COO of New Iridium. Contact Info: 1 email address
- Garrett Miyake: Co-Founder & CTO of New Iridium. Contact Info: 1 email address
View details of New Iridium's Founder profiles and Board Members
New Iridium's employee count trend
New Iridium has 8 employees as of Mar 26. Here is New Iridium's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
New Iridium's Competitors and alternates
Top competitors of New Iridium include Sai Life Sciences, Liverpool ChiroChem and NFIL. Here is the list of Top 10 competitors of New Iridium, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Sai Life Sciences 1999, Hyderabad (India), Public | Provider of drug discovery, developing, and manufacturing of complex small molecules | $108M | 66/100 | |
2nd | Liverpool ChiroChem 2014, Liverpool (United Kingdom), Acquired | Small organic molecule supplier for biotech/pharmaceutical R&D | $11.1M | 51/100 | |
3rd | CRAMS company specialising in the custom chemical synthesis and manufacturing of fluorinated compounds | - | - | 51/100 | |
4th | GL Chemtec International 2002, Oakville (Canada), Acquired | Discovery stage CRO specializing in custom synthesis of fine chemicals and intermediates | - | - | 51/100 |
5th | Bioduro 2005, San Diego (United States), Acquired | Global CRDMO providing integrated drug discovery, development, and manufacturing services | - | 49/100 | |
6th | Integrated drug discovery and preclinical development service provider | - | 48/100 | ||
7th | Integrated drug discovery and preclinical development services | - | 48/100 | ||
8th | Provider of consulting services in the field of chemical research and development through artificial intelligence chemical synthesis | $71M | 46/100 | ||
9th | New Iridium 2016, Boulder (United States), Seed | Manufacturer of phenoxazine and dihydrophenazine | $2.65M | 45/100 | |
10th | Alzheimer's Drug Discovery 1998, New York City (United States), Funding Raised | Foundation aims to discover drugs to prevent, treat, and cure alzheimer's disease | - | 45/100 |
Looking for more details on New Iridium's competitors? Click here to see the top ones
New Iridium's Investments and acquisitions
New Iridium has made no investments or acquisitions yet.
News related to New Iridium
Media has covered New Iridium for 1 event in last 1 year.
•
New Iridium secures $2.65M seed funding for bio-based acetic acid, ethyl acetate.Biofuels Digest•Jun 12, 2025•New Iridium, National Science Foundation, DOE, ENERGYWERX
•
•
Braskem partnering with photocatalysis startup New Iridium on decarbonization technologiesChemengonline•Apr 15, 2023•Braskem, New Iridium
•
New Iridium launches new class of photocatalysts for Birch reductionGlobeNewswire•Dec 08, 2020•New Iridium
Are you a Founder ?
FAQs about New Iridium
Explore our recently published companies
- Godhan Masala Foods - Delhi based, 2014 founded, Funding Raised company
- Minniedaleprojects - United Kingdom based, 2015 founded, Unfunded company
- Rivalia Chemical - New York City based, 2022 founded, Seed company
- My-Maintenance - United Kingdom based, Unfunded company
- Svenskafukt - Sweden based, Unfunded company
- Ibmay - Germany based, Unfunded company
